{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:05:48Z","timestamp":1789005948324,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.carrev.2025.08.011","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:09:58Z","timestamp":1756742998000},"page":"88-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy and safety of protamine sulfate following carotid artery stenting"],"prefix":"10.1016","volume":"86","author":[{"given":"William","family":"Nicholson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled I.","family":"Alnahhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Borenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keivan","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Talutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.carrev.2025.08.011_bb0005","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2468-2667(21)00230-9","article-title":"Primary stroke prevention worldwide: translating evidence into action","volume":"7","author":"Owolabi","year":"2022","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.011_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"10305","key":"10.1016\/j.carrev.2025.08.011_bb0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(21)01910-3","article-title":"Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy","volume":"398","author":"Halliday","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.carrev.2025.08.011_bb0020","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jvs.2010.11.122","article-title":"Reporting standards for carotid interventions from the society for vascular Surgery","volume":"53","author":"Timaran","year":"2011","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.carrev.2025.08.011_bb0025","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3171\/2017.8.JNS171142","article-title":"Risk of intracranial hemorrhage after carotid artery stenting versus endarterectomy: a population-based study","volume":"129","author":"Hussain","year":"2018","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.carrev.2025.08.011_bb0030","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejvs.2021.01.039","article-title":"Editor\u2019s choice \u2013 early and late outcomes after transcarotid revascularisation for internal carotid artery stenosis: a systematic review and meta-analysis","volume":"61","author":"Galyfos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"23","key":"10.1016\/j.carrev.2025.08.011_bb0035","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1001\/jama.2019.18441","article-title":"Association of transcarotid artery revascularization vs transfemoral carotid artery stenting with stroke or death among patients with carotid artery stenosis","volume":"322","author":"Schermerhorn","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.011_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2020.04.526","article-title":"Protamine use in transfemoral carotid artery stenting is not associated with an increased risk of thromboembolic events","volume":"73","author":"Liang","year":"2021","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.carrev.2025.08.011_bb0045","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/STROKEAHA.119.027388","article-title":"Nationwide trends in carotid endarterectomy and carotid artery stenting in the post-CREST era","volume":"51","author":"Cole","year":"2020","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.carrev.2025.08.011_bb0050","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jvs.2004.10.022","article-title":"Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase","volume":"40","author":"Hobson","year":"2004","journal-title":"J Vasc Surg"},{"issue":"5","key":"10.1016\/j.carrev.2025.08.011_bb0055","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jvs.2015.04.460","article-title":"Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal","volume":"62","author":"Kwolek","year":"2015","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.carrev.2025.08.011_bb2005","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/17085381211067047","article-title":"Protamine use in transcarotid arterial revascularization","volume":"31","author":"Kanitra","year":"2022","journal-title":"Vascular"},{"issue":"6","key":"10.1016\/j.carrev.2025.08.011_bb0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ejvs.2020.08.047","article-title":"Editor\u2019s choice - protamine reduces serious bleeding complications associated with carotid endarterectomy in asymptomatic patients without increasing the risk of stroke, myocardial infarction, or death in a large national analysis","volume":"60","author":"Stone","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"10.1016\/j.carrev.2025.08.011_bb0070","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.jvs.2020.02.019","article-title":"Protamine use in transcarotid artery revascularization is associated with lower risk of bleeding complications without higher risk of thromboembolic events","volume":"72","author":"Liang","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2025.08.011_bb0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2019.02.004","article-title":"Thrombotic and hemorrhagic burden in women: gender-related issues in the response to antithrombotic therapies","volume":"286","author":"Renda","year":"2019","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2025.08.011_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jjcc.2020.12.004","article-title":"Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention: start with what is right rather than what is acceptable","volume":"78","author":"Nakamura","year":"2021","journal-title":"J Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2025.08.011_bb0085","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1053\/j.jvca.2017.04.019","article-title":"Perioperative management of patients with end-stage renal disease","volume":"31","author":"Kanda","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.011_bb0090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ehjqcco\/qcz066","article-title":"Association between heart failure and perioperative outcomes in patients undergoing non-cardiac surgery","volume":"7","author":"Smilowitz","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.011_bb0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","article-title":"Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN prospective cohort","volume":"126","author":"Roshanov","year":"2017","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.carrev.2025.08.011_bb0100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejvs.2022.08.005","article-title":"Editor\u2019s choice - sex differences in response to administration of heparin during non-cardiac arterial procedures","volume":"64","author":"Roosendaal","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"10.1016\/j.carrev.2025.08.011_bb0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5090\/kjtcs.19.055","article-title":"Risk factors associated with difficult reversal of heparin by protamine sulfate in cardiopulmonary bypass: an ignored issue","volume":"53","author":"Ku","year":"2020","journal-title":"Korean J Thorac Cardiovasc Surg"},{"issue":"12","key":"10.1016\/j.carrev.2025.08.011_bb0110","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.011_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1024\/0301-1526\/a000490","article-title":"Gender differences in patients with carotid stenosis","volume":"45","author":"Stoberock","year":"2016","journal-title":"Vasa"},{"issue":"4","key":"10.1016\/j.carrev.2025.08.011_bb0120","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/STROKEAHA.108.540781","article-title":"Sex differences in stroke epidemiology: a systematic review","volume":"40","author":"Appelros","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.carrev.2025.08.011_bb0125","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/STROKEAHA.108.542894","article-title":"Gender differences in stroke incidence and poststroke disability in the Framingham heart study","volume":"40","author":"Petrea","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.carrev.2025.08.011_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.medntd.2019.100025","article-title":"Gender differences in cardiovascular disease","volume":"4","author":"Gao","year":"2019","journal-title":"Med Novel Technol Devices"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.011_bb0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/000331979604700102","article-title":"Synergistic inhibitory effect of angiotensin-converting enzyme inhibitor and heparin on intimal hyperplasia after rat aorta injury","volume":"47","author":"Park","year":"1996","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.011_bb0140","first-page":"70","article-title":"Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin","volume":"114","author":"Kim","year":"2015","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.011_bb0145","article-title":"Network meta-analysis of randomized trials on the safety of vascular closure devices for femoral arterial puncture site haemostasis","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925004154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925004154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:27:58Z","timestamp":1778819278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925004154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["S1553838925004154"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.08.011","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of protamine sulfate following carotid artery stenting","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}